CANDID THERAPEUTICS Trademark

Trademark Overview


On Monday, September 9, 2024, a trademark application was filed for CANDID THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CANDID THERAPEUTICS trademark a serial number of 98741497. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, September 17, 2025. This trademark is owned by Candid Therapeutics, Inc.. The CANDID THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Anti-inflammatory preparations; Antibodies for medical purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral diseases; Anti-inflammatories; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of infectious diseases; none of the foregoing being pharmaceutical preparations in the nature of antifungals and none of the foregoing related to supplements, vitamin preparations, or dietetic foods

Pharmaceutical drug development services; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies; Research and development services in the field of immunology; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; none of the foregoing related to pharmaceutical preparations in the nature of antifungals and none of the foregoing related to supplements, vitamin preparations, or dietetic foods
candid therapeutics

General Information


Serial Number98741497
Word MarkCANDID THERAPEUTICS
Filing DateMonday, September 9, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, September 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word CANDID appearing in a stylized font with the C and D appearing larger than the rest of the lettering. A dotted swirl design extends from the C to the D over all the letters. Below CANDID is the word THERAPEUTICS appearing between two horizontal lines.
Goods and ServicesAnti-inflammatory preparations; Antibodies for medical purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral diseases; Anti-inflammatories; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of infectious diseases; none of the foregoing being pharmaceutical preparations in the nature of antifungals and none of the foregoing related to supplements, vitamin preparations, or dietetic foods
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical drug development services; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies; Research and development services in the field of immunology; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; none of the foregoing related to pharmaceutical preparations in the nature of antifungals and none of the foregoing related to supplements, vitamin preparations, or dietetic foods

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCandid Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, September 9, 2024NEW APPLICATION ENTERED
Thursday, October 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 18, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Wednesday, March 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 19, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 19, 2025NON-FINAL ACTION E-MAILED
Thursday, May 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 10, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 10, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 17, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 17, 2025SUSPENSION LETTER WRITTEN
Wednesday, September 17, 2025LETTER OF SUSPENSION E-MAILED